SUBSCRIBE
SUBSCRIBE
News   Policy

Delaware Court Denies Plaintiffs’ Request to Enjoin CVS Corporation/Caremark Rx Merger

February 26, 2007 | 
1 min read
NASHVILLE, Tenn.--(BUSINESS WIRE)--Caremark Rx, Inc. (NYSE: CMX) today announced that the Delaware Court of Chancery has denied plaintiffs’ motion to enjoin Caremark’s planned merger with CVS Corporation (NYSE: CVS).
Legal Mergers & acquisitions Regulatory
MORE ON THIS TOPIC
FDA commissioner Marty Makary speaking on a Youtube video, wearing a dark suit and a blue tie
FDA
Trump signs off on plan to oust embattled FDA Commissioner Marty Makary: report
May 8, 2026
 · 
2 min read
 · 
Annalee Armstrong
Businessman carrying a stopwatch on a progress bar illustrating last minute deadline to complete a business project
Alzheimer’s disease
Biogen, Eisai hit with 3-month delay for starting SubQ Alzheimer’s therapy
May 8, 2026
 · 
2 min read
 · 
Tristan Manalac
The white plane flies against the blue sky, leaving a white trail. Vector illustration
FDA
FDA reverses course on Atara, Pierre Fabre’s twice-rejected cell therapy after Prasad’s exit
May 7, 2026
 · 
3 min read
 · 
Heather McKenzie
Big fish eats small, takeover of the company. Art collage.
Deals
Angelini inks $4.1B Catalyst buy to enter US rare disease market
May 7, 2026
 · 
2 min read
 · 
Gabrielle Masson